Erectile dysfunction: A review of a common problem in rapid evolution

Primary Care Update for Ob/Gyns

Volumn 7, Issue 3, 2000, Pages 124-129

  Levine, Laurence A ^a  

^a R ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENTOLAMINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE;

AGE; DYSPEPSIA; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; MALE; NOSE CONGESTION; PRIORITY JOURNAL; REVIEW; VISUAL DISORDER;

EID: 0034612056     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(00)00033-0     Document Type: Article

References (24)

1. Impotence NIH Consensus Conference . JAMA. 270:1993;83-90.
2. Feldman H.A., Goldstein I., Hatzichristou D.G., Kranse R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates Results of the Massachusetts Male Aging Study . J Urol. 151:1994;54-61.
3. Laumann E.O., Paik A., Rosen R. Sexual dysfunction in the United States Prevalence and predictors . JAMA. 281:1999;537-544.
4. Benet A.E., Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am. 22:1995;699-709.
5. David-Joseph B., Tiefer L., Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology. 45:1995;498-502.
6. Levine L.A. Erectile dysfunction Causes, diagnosis and treatment . Compr Ther. 15:1989;54-58.
7. Leiblum S.R. Definition and classification of female sexual disorders. Int J Impot Res. 10:(Suppl 2):1998;S104-S106.
8. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndrome. In J Impot Res 1998;(Suppl 2):S84-90.
9. Lue T.F. Impotence A patient's goal-directed approach to treatment . World J Urol. 8:1990;67-74.
10. Jarow J.P., Nana-Sinkam P., Sabbagh M., et al. Outcome analysis of a goal directed therapy for impotence. J Urol. 155:1996;1609-1612.
11. Dewire D.M. Evaluation and treatment of erectile dysfunction. Am Fam Physician. 53:1996;2101-2108.
12. Graham C.W., Regan J.B. Blinded, clinical trial of testosterone enanthate in impotent men with low or low-normal serum testosterone levels. Int J Impot Res. 4:(Suppl 2):1992;S144.
13. Levine LA, Lenting EL. Use of nocturnal penile tumescence and rigidity monitoring in the evaluation of male erectile dysfunction. In: Urologic Clinics of North America. Arnold Melman, ed. Philadelphia: W.B. Saunders, 1995:72, 775-88.
14. Lewis R.W., Witherington R. External vacuum therapy for erectile dysfunction Use and results . World J Urol. 15:1997;78-82.
15. Linet O.I., Orgring F.G. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 334:1996;873-877.
16. Padma-Nathan H., Hellstrom W.J.G., Kaiser F.E., et al. Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med. 336:1997;1-7.
17. Montague D.K., Barada J.H., Bekler A.M., et al. Clinical guidelines panel on erectile dysfunction. Summary report on the treatment of organic erectile dysfunction. J Urol. 156:1996;2007-2011.
18. Heaton J.P., Morales A., Adams M.A., et al. Recovery of erectile function by the oral administration of apomorphine. Urol. 45:1995;200-206.
19. Zorgniotti A.W. Experience with buccal phentolamine mesylate for impotence. Int J Impot Res. 6:1994;37-41.
20. Goldstein I., Lue T., Padma-Nathan H., et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 338:1998;1397-1404.
21. Morales A., Gingell C., Collins M., Wicker P.A., Osterloh I.H. Clinical safety of oral sildenafil citrate (Viagra™) in the treatment of erectile dysfunction. Int J Impot Res. 10:1998;69-74.
22. Webb D.J., Freestone S., Allen M.J., Muirhead G.J. Sildenafil citrate and blood-pressure-lowering drugs Results of drug interaction studies with an organic nitrate and a calcium antagonist . Am J Cardiol. 83:1999;21C-218.
23. Muller J.E., Mittleman M.A., Maclure M., et al. Triggering myocardial infarction by sexual activity. JAMA. 275:1996;1405-1409.
24. Viagra® (sildenafil citrate). Prescribing information. New York: Pfizer Inc.